Stock Performance and Market Context
On 25 June 2026, Amanta Healthcare Ltd’s stock price surged to Rs.164.90, setting a new 52-week and all-time high. Despite closing the day with a slight decline of 0.68%, the stock remains well above its key moving averages, trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning indicates sustained buying interest over multiple time frames.
In comparison, the broader Sensex index recorded a modest gain of 0.14% on the same day, while the Pharmaceuticals & Biotechnology sector outperformed Amanta Healthcare by 0.4%. The stock’s intraday low was Rs.156.50, representing a 3.9% dip from its peak during the session, highlighting some volatility around the record price.
Historical Price and Relative Performance
Amanta Healthcare Ltd’s price trajectory over recent periods has been robust. The stock outperformed the Sensex significantly over the short and medium term, with a 1-week gain of 10.22% versus the Sensex’s -0.40%, and a 1-month gain of 21.89% compared to the Sensex’s 0.80%. Over three months, the stock soared by 65.05%, dwarfing the Sensex’s 2.43% rise.
Year-to-date, the stock has appreciated by 48.80%, contrasting with the Sensex’s decline of 9.53%. However, over longer horizons such as one year, three years, five years, and ten years, Amanta Healthcare’s stock price has remained flat, while the Sensex posted gains ranging from 22.42% to 192.07%. This suggests that the recent rally is a relatively new development in the company’s market journey.
Valuation Metrics and Financial Ratios
At the close on 25 June 2026, the stock was priced at Rs.161.75, reflecting a price-to-earnings (P/E) ratio of 39 times on a trailing twelve months (TTM) basis. The price-to-book value (P/BV) stood at 2.87 times, while the enterprise value to EBITDA (EV/EBITDA) multiple was 13.10 times. Other valuation multiples included an EV/EBIT of 19.07 times and an EV/sales ratio of 2.73 times.
Dividend metrics were not available, with no dividend yield or payout reported. The company’s market capitalisation is classified as micro-cap, indicating a relatively small market size within the sector.
Technical Analysis and Trend Assessment
The overall technical trend for Amanta Healthcare Ltd is mildly bullish as of 25 June 2026, having shifted from a bullish stance on 15 June 2026 when the stock was trading at Rs.156.35. Key technical indicators present a mixed picture: the MACD and Bollinger Bands signal bullish momentum, while the RSI is bearish on a weekly basis. The Dow Theory shows a mildly bearish weekly trend but a bullish monthly trend, reflecting some divergence in short- and long-term technical signals.
Immediate support is identified at Rs.93.10, the 52-week low, while resistance levels include Rs.141.33 (20-day moving average) and Rs.119.18 (100-day moving average). The all-time high of Rs.164.90 now represents a major resistance level, which the stock has just surpassed intraday.
Trading Volumes and Delivery Trends
Trading activity has intensified in recent weeks. Delivery volumes over the past month increased by 119.54%, with a notable spike on 24 June 2026 when delivery volume reached 15,600 shares, accounting for 18.50% of total volume. This was significantly higher than the 5-day average delivery volume of 4,940 shares (4.89% of total volume) and the trailing one-month average of 1.28 lakh shares (24.31% of total volume). The previous month’s average delivery volume was 58,080 shares, representing 53.78% of total volume, indicating a shift in trading patterns.
Quality and Financial Health Overview
Amanta Healthcare Ltd’s overall quality assessment reflects some areas of concern alongside strengths. The management risk is rated as average, while growth and capital structure are below average. Over the past five years, sales have declined by 2.00%, but EBIT has grown by 9.30%. The company’s average EBIT to interest coverage ratio is 1.53 times, indicating relatively weak ability to cover interest expenses from operating profit.
Leverage metrics show moderate debt levels, with an average debt to EBITDA ratio of 3.54 and a high net debt to equity ratio of 1.99. Sales to capital employed ratio stands at 0.74 times, and the tax ratio is 29.59%. Return on capital employed (ROCE) and return on equity (ROE) are weak at 13.00% and 8.18% respectively. Institutional holdings are moderate at 13.72%, and there is no promoter share pledging.
Short-Term Financial Trends
Recent quarterly data shows a flat short-term financial trend as of March 2026. Positive highlights include the highest operating profit to interest ratio of 3.52 times and net sales reaching a quarterly peak of ₹76.99 crores. However, operating profit to net sales ratio was at its lowest quarterly level of 19.42%, indicating some margin pressure.
Summary of the Stock’s Journey to the Peak
Amanta Healthcare Ltd’s stock has demonstrated a remarkable ascent in recent months, culminating in the all-time high price of Rs.164.90 on 25 June 2026. This milestone reflects a combination of strong short-term price appreciation, increased trading volumes, and sustained technical momentum. While the company’s longer-term financial and quality metrics present a mixed picture, the recent market performance underscores a period of renewed investor focus and trading activity.
The stock’s ability to maintain levels above key moving averages and the mild bullish technical trend suggest that the current price peak is supported by underlying market dynamics. However, the valuation multiples indicate a premium pricing relative to earnings and book value, consistent with the stock’s micro-cap status and sector characteristics.
